Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.
Identifieur interne : 002695 ( Main/Exploration ); précédent : 002694; suivant : 002696Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.
Auteurs : Fary Khan [Australie] ; Bhasker AmatyaSource :
- Journal of neuro-oncology [ 1573-7373 ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Analyse de survie (MeSH), Bases de données factuelles (statistiques et données numériques), Caractéristiques de l'habitat (MeSH), Enquêtes et questionnaires (MeSH), Facteurs sexuels (MeSH), Facteurs âges (MeSH), Femelle (MeSH), Humains (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Qualité de vie (MeSH), Relations interpersonnelles (MeSH), Résultat thérapeutique (MeSH), Sujet âgé (MeSH), Troubles de la cognition (étiologie), Tumeurs du cerveau (classification), Tumeurs du cerveau (complications), Tumeurs du cerveau (psychologie), Tumeurs du cerveau (rééducation et réadaptation), Études longitudinales (MeSH), Études rétrospectives (MeSH), Évolution de la maladie (MeSH).
- MESH :
- psychologie : Tumeurs du cerveau.
- rééducation et réadaptation : Tumeurs du cerveau.
- statistiques et données numériques : Bases de données factuelles.
- étiologie : Troubles de la cognition.
- classification : Adulte, Adulte d'âge moyen, Analyse de survie, Caractéristiques de l'habitat, Enquêtes et questionnaires, Facteurs sexuels, Facteurs âges, Femelle, Humains, Jeune adulte, Mâle, Qualité de vie, Relations interpersonnelles, Résultat thérapeutique, Sujet âgé, Tumeurs du cerveau, Études longitudinales, Études rétrospectives, Évolution de la maladie.
English descriptors
- KwdEn :
- Adult (MeSH), Age Factors (MeSH), Aged (MeSH), Brain Neoplasms (classification), Brain Neoplasms (complications), Brain Neoplasms (psychology), Brain Neoplasms (rehabilitation), Cognition Disorders (etiology), Databases, Factual (statistics & numerical data), Disease Progression (MeSH), Female (MeSH), Humans (MeSH), Interpersonal Relations (MeSH), Longitudinal Studies (MeSH), Male (MeSH), Middle Aged (MeSH), Quality of Life (MeSH), Residence Characteristics (MeSH), Retrospective Studies (MeSH), Sex Factors (MeSH), Surveys and Questionnaires (MeSH), Survival Analysis (MeSH), Treatment Outcome (MeSH), Young Adult (MeSH).
- MESH :
- classification : Brain Neoplasms.
- complications : Brain Neoplasms.
- etiology : Cognition Disorders.
- psychology : Brain Neoplasms.
- rehabilitation : Brain Neoplasms.
- statistics & numerical data : Databases, Factual.
- Adult, Age Factors, Aged, Disease Progression, Female, Humans, Interpersonal Relations, Longitudinal Studies, Male, Middle Aged, Quality of Life, Residence Characteristics, Retrospective Studies, Sex Factors, Surveys and Questionnaires, Survival Analysis, Treatment Outcome, Young Adult.
Abstract
To examine factors impacting long-term functional outcomes and psychological sequelae in persons with primary brain tumours (BT) in an Australian community cohort. Participants (n = 106) following definitive treatment for BT in the community were reviewed in rehabilitation clinics to assess impact on participants' current activity and restriction in participation, using validated questionnaires: Functional Independence Measure (FIM), Perceived Impact Problem Profile (PIPP), Depression Anxiety Stress Scale, Cancer Rehabilitation Evaluation System-Short Form and Cancer Survivor Unmet Needs Measure. Mean age of the participants was 51 years (range 21-77 years), majority were female (56 %) with median time since BT diagnosis 2.1 years and a third (39 %) had high grade tumours. Majority showed good functional recovery (median motor FIM score 75). Over half reported pain (56 %), of which 42 % had headaches. Other impairments included: ataxia (44 %), seizures (43 %); paresis (37 %), cognitive dysfunction (36 %) and visual impairment (35 %). About 20 % reported high levels of depression, compared with only 13 % in an Australian normative sample. Two-third (60 %) participants reported highest impact on the PIPP subscales for psychological wellbeing (scores of >3 on 6-point scale) and participation (45 %). Factors significantly associated with poorer current level of functioning and wellbeing included: younger participants (≤40 years), recent diagnoses, aggressive tumour types and presence of pain. No significant differences in scale scores were found across various treatments (surgery, chemotherapy or radiotherapy) on outcomes used. Rehabilitation for BT survivors is challenging and requires long-term management of psychological sequelae impacting activity and participation. More research into participatory limitation is needed to guide treating clinicians.
DOI: 10.1007/s11060-012-1024-z
PubMed: 23292152
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.</title>
<author><name sortKey="Khan, Fary" sort="Khan, Fary" uniqKey="Khan F" first="Fary" last="Khan">Fary Khan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rehabilitation, Royal Melbourne Hospital, 34-54 Poplar Road, Parkville, VIC 3052, Australia. fary.khan@mh.org.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Rehabilitation, Royal Melbourne Hospital, 34-54 Poplar Road, Parkville, VIC 3052</wicri:regionArea>
<wicri:noRegion>VIC 3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Amatya, Bhasker" sort="Amatya, Bhasker" uniqKey="Amatya B" first="Bhasker" last="Amatya">Bhasker Amatya</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23292152</idno>
<idno type="pmid">23292152</idno>
<idno type="doi">10.1007/s11060-012-1024-z</idno>
<idno type="wicri:Area/Main/Corpus">002743</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">002743</idno>
<idno type="wicri:Area/Main/Curation">002743</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">002743</idno>
<idno type="wicri:Area/Main/Exploration">002743</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.</title>
<author><name sortKey="Khan, Fary" sort="Khan, Fary" uniqKey="Khan F" first="Fary" last="Khan">Fary Khan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rehabilitation, Royal Melbourne Hospital, 34-54 Poplar Road, Parkville, VIC 3052, Australia. fary.khan@mh.org.au</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Rehabilitation, Royal Melbourne Hospital, 34-54 Poplar Road, Parkville, VIC 3052</wicri:regionArea>
<wicri:noRegion>VIC 3052</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Amatya, Bhasker" sort="Amatya, Bhasker" uniqKey="Amatya B" first="Bhasker" last="Amatya">Bhasker Amatya</name>
</author>
</analytic>
<series><title level="j">Journal of neuro-oncology</title>
<idno type="eISSN">1573-7373</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Age Factors (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Brain Neoplasms (classification)</term>
<term>Brain Neoplasms (complications)</term>
<term>Brain Neoplasms (psychology)</term>
<term>Brain Neoplasms (rehabilitation)</term>
<term>Cognition Disorders (etiology)</term>
<term>Databases, Factual (statistics & numerical data)</term>
<term>Disease Progression (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Interpersonal Relations (MeSH)</term>
<term>Longitudinal Studies (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Quality of Life (MeSH)</term>
<term>Residence Characteristics (MeSH)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Sex Factors (MeSH)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Survival Analysis (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Analyse de survie (MeSH)</term>
<term>Bases de données factuelles (statistiques et données numériques)</term>
<term>Caractéristiques de l'habitat (MeSH)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Facteurs sexuels (MeSH)</term>
<term>Facteurs âges (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Qualité de vie (MeSH)</term>
<term>Relations interpersonnelles (MeSH)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Troubles de la cognition (étiologie)</term>
<term>Tumeurs du cerveau (classification)</term>
<term>Tumeurs du cerveau (complications)</term>
<term>Tumeurs du cerveau (psychologie)</term>
<term>Tumeurs du cerveau (rééducation et réadaptation)</term>
<term>Études longitudinales (MeSH)</term>
<term>Études rétrospectives (MeSH)</term>
<term>Évolution de la maladie (MeSH)</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Brain Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Brain Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cognition Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Tumeurs du cerveau</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Brain Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Brain Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Tumeurs du cerveau</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Databases, Factual</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Bases de données factuelles</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Troubles de la cognition</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Interpersonal Relations</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Quality of Life</term>
<term>Residence Characteristics</term>
<term>Retrospective Studies</term>
<term>Sex Factors</term>
<term>Surveys and Questionnaires</term>
<term>Survival Analysis</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Caractéristiques de l'habitat</term>
<term>Enquêtes et questionnaires</term>
<term>Facteurs sexuels</term>
<term>Facteurs âges</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Qualité de vie</term>
<term>Relations interpersonnelles</term>
<term>Résultat thérapeutique</term>
<term>Sujet âgé</term>
<term>Tumeurs du cerveau</term>
<term>Études longitudinales</term>
<term>Études rétrospectives</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To examine factors impacting long-term functional outcomes and psychological sequelae in persons with primary brain tumours (BT) in an Australian community cohort. Participants (n = 106) following definitive treatment for BT in the community were reviewed in rehabilitation clinics to assess impact on participants' current activity and restriction in participation, using validated questionnaires: Functional Independence Measure (FIM), Perceived Impact Problem Profile (PIPP), Depression Anxiety Stress Scale, Cancer Rehabilitation Evaluation System-Short Form and Cancer Survivor Unmet Needs Measure. Mean age of the participants was 51 years (range 21-77 years), majority were female (56 %) with median time since BT diagnosis 2.1 years and a third (39 %) had high grade tumours. Majority showed good functional recovery (median motor FIM score 75). Over half reported pain (56 %), of which 42 % had headaches. Other impairments included: ataxia (44 %), seizures (43 %); paresis (37 %), cognitive dysfunction (36 %) and visual impairment (35 %). About 20 % reported high levels of depression, compared with only 13 % in an Australian normative sample. Two-third (60 %) participants reported highest impact on the PIPP subscales for psychological wellbeing (scores of >3 on 6-point scale) and participation (45 %). Factors significantly associated with poorer current level of functioning and wellbeing included: younger participants (≤40 years), recent diagnoses, aggressive tumour types and presence of pain. No significant differences in scale scores were found across various treatments (surgery, chemotherapy or radiotherapy) on outcomes used. Rehabilitation for BT survivors is challenging and requires long-term management of psychological sequelae impacting activity and participation. More research into participatory limitation is needed to guide treating clinicians.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23292152</PMID>
<DateCompleted><Year>2013</Year>
<Month>09</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7373</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>111</Volume>
<Issue>3</Issue>
<PubDate><Year>2013</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neuro-oncology</Title>
<ISOAbbreviation>J Neurooncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour.</ArticleTitle>
<Pagination><MedlinePgn>355-66</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11060-012-1024-z</ELocationID>
<Abstract><AbstractText>To examine factors impacting long-term functional outcomes and psychological sequelae in persons with primary brain tumours (BT) in an Australian community cohort. Participants (n = 106) following definitive treatment for BT in the community were reviewed in rehabilitation clinics to assess impact on participants' current activity and restriction in participation, using validated questionnaires: Functional Independence Measure (FIM), Perceived Impact Problem Profile (PIPP), Depression Anxiety Stress Scale, Cancer Rehabilitation Evaluation System-Short Form and Cancer Survivor Unmet Needs Measure. Mean age of the participants was 51 years (range 21-77 years), majority were female (56 %) with median time since BT diagnosis 2.1 years and a third (39 %) had high grade tumours. Majority showed good functional recovery (median motor FIM score 75). Over half reported pain (56 %), of which 42 % had headaches. Other impairments included: ataxia (44 %), seizures (43 %); paresis (37 %), cognitive dysfunction (36 %) and visual impairment (35 %). About 20 % reported high levels of depression, compared with only 13 % in an Australian normative sample. Two-third (60 %) participants reported highest impact on the PIPP subscales for psychological wellbeing (scores of >3 on 6-point scale) and participation (45 %). Factors significantly associated with poorer current level of functioning and wellbeing included: younger participants (≤40 years), recent diagnoses, aggressive tumour types and presence of pain. No significant differences in scale scores were found across various treatments (surgery, chemotherapy or radiotherapy) on outcomes used. Rehabilitation for BT survivors is challenging and requires long-term management of psychological sequelae impacting activity and participation. More research into participatory limitation is needed to guide treating clinicians.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName>
<ForeName>Fary</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Rehabilitation, Royal Melbourne Hospital, 34-54 Poplar Road, Parkville, VIC 3052, Australia. fary.khan@mh.org.au</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Amatya</LastName>
<ForeName>Bhasker</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>01</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Neurooncol</MedlineTA>
<NlmUniqueID>8309335</NlmUniqueID>
<ISSNLinking>0167-594X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
<QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007398" MajorTopicYN="N">Interpersonal Relations</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012111" MajorTopicYN="N">Residence Characteristics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year>
<Month>07</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2012</Year>
<Month>12</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23292152</ArticleId>
<ArticleId IdType="doi">10.1007/s11060-012-1024-z</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Brain Pathol. 1993 Jul;3(3):255-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8293185</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Phys Med Rehabil Clin N Am. 2007 Nov;18(4):899-924, viii</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17967368</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer. 1997 Jul 15;80(2):258-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9217039</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Palliat Nurs. 2010 Jan;16(1):24-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20090660</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer. 2010 Jun 15;116(12):3034-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20564409</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurooncol. 2012 May;107(3):537-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22124725</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Disabil Rehabil. 2009;31(13):1066-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19802924</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychooncology. 1998 Mar-Apr;7(2):112-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9589509</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19474385</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychosomatics. 1999 Jan-Feb;40(1):64-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9989123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurol Sci. 2005 May;26 Suppl 1:S51-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15883697</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):637-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9219755</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Phys Med Rehabil. 1993 Jun;74(6):566-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8503745</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gynecol Oncol. 2007 Feb;104(2):381-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17027072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Phys Med Rehabil. 1998 Mar;79(3):235-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9523772</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Qual Life Res. 1992 Feb;1(1):19-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1301111</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychooncology. 2003 Dec;12(8):803-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14681953</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pers Assess. 2000 Oct;75(2):308-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11020147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Support Care Cancer. 2007 May;15(5):515-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17120068</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Phys Med Rehabil. 2006 Jul;85(7):568-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16788387</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nurs Inq. 2004 Mar;11(1):43-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14962346</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PM R. 2011 Aug;3(8):746-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21871419</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer. 1991 Sep 15;68(6):1406-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1873793</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Semin Radiat Oncol. 2003 Jul;13(3):248-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12903014</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Phys Med Rehabil. 2011 May;90(5 Suppl 1):S50-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21765264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer. 2001 Aug 15;92(4 Suppl):1029-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11519030</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Neurosci. 2009 Jan;16(1):74-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19022673</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Disabil Rehabil. 2009;31(13):1038-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19116809</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Res Nurs Health. 1990 Aug;13(4):227-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2197679</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Phys Med Rehabil. 2001 Nov;82(11):1540-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11689973</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Control. 2000 Nov-Dec;7(6):523-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11088061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurol. 2008 Jun;255(6):820-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18500499</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Phys Med Rehabil. 2000 Jul-Aug;79(4):327-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10892618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Rehabil Med. 2008 Aug;40(8):665-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19020701</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><noCountry><name sortKey="Amatya, Bhasker" sort="Amatya, Bhasker" uniqKey="Amatya B" first="Bhasker" last="Amatya">Bhasker Amatya</name>
</noCountry>
<country name="Australie"><noRegion><name sortKey="Khan, Fary" sort="Khan, Fary" uniqKey="Khan F" first="Fary" last="Khan">Fary Khan</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002695 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002695 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= PoplarV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:23292152 |texte= Factors associated with long-term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23292152" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a PoplarV1
![]() | This area was generated with Dilib version V0.6.37. | ![]() |